PeDRA 2025Abstract 071Clinical trial
Improvement in Atopic Dermatitis Signs and Symptoms With Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.15% or 0.05%
Results From the 52-Week Phase 3 INTEGUMENT-OLE Trial in Patients Aged ≥2 Years
Hong HCH, Simpson E, Eichenfield LF, Golant A, Hebert AA, Paller A, Armstrong A, Gold LS, Silverberg JI, Krupa D, Burnett P, Hanna D, Seal MS, Stephenson B
PeDRA Annual Conference 2025Minneapolis, 9–11 Oct 2025 · published in JID 9 Mar 2026
Topics: Atopic dermatitis & eczema
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/s0022-202x(26)00607-x · Not in PubMed: details from Crossref